Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management

The latest paper is now available online in Human Reproduction. Abstract STUDY QUESTION: What is the load, distribution and added clinical value of secondary findings (SFs) identified in exome sequencing (ES) of patients with non-obstructive azoospermia (NOA)? SUMMARY ANSWER: One in 28 NOA cases carried an identifiable, medically actionable SF. WHAT IS KNOWN ALREADY: In […]